April 28, 2022 · STOCK Act disclosure
Representative Michael T. McCaul (Republican-TX) bought Verve Therapeutics Inc, a stock transaction, valued at $1,001 - $15,000. The trade took place on April 28, 2022 and was disclosed on May 25, 2022 (owner: DC). Members of Congress must report such transactions within 45 days under the STOCK Act.